I think some of the criticisms may be the over-reporting of data overall, which can lead to a high volume and low value. It's not necessarily that there isn't a high degree of reporting. Our members submit millions of STRs to FINTRAC over a multi-year period. There's certainly a high level of investment in that aspect of the regime.
What we'd like to see here are the technical amendments that we've suggested, which will help drive predictability and transparency in application and help to prevent over-reporting. Clarity in regulatory expectations will assist organizations in meeting those expectations properly in analyzing risk, focusing their efforts on pinpointing the needles in the haystack and providing reporting to FINTRAC.
We've also seen other developments in the regime such as private-to-private information sharing and enhanced beneficial ownership transparency. All of these help to target risk and lead to a more effective and efficient AML regime.